Health ❯ Metabolic Health

Obesity

Weight Loss Insulin Resistance Dietary Impact Type 2 Diabetes Risk Factors Statistics Fat Distribution Fat Accumulation Inflammation Type-2 Diabetes Clinical Trials Brown Fat Neck Size Weight Loss Treatments Drug Development Pharmaceuticals Body Composition Cardiovascular-Kidney-Metabolic Syndrome Diabetes GLP-1 Receptor Agonists Energy Expenditure Prediabetes Anti-obesity therapeutics

Zealand Pharma Taps Generate’s AI for Obesity Programs in Potential $1.2 Billion Deal

Generate will design and test multispecific proteins with Zealand responsible for later clinical development and global commercialization.

Study Finds Early CKM Risk and Measurable Carotid Injury in Young Adults

Early Evidence Suggests GLP‑1 Weight Drugs Can Raise Testosterone and Improve Sperm in Men With Obesity

Major U.S. Societies Publish First Clinical Guideline for Cardiovascular‑Kidney‑Metabolic Syndrome

Advanced CKM Stages Linked to Higher Cancer Risk in Major Japanese Study

Zealand Pharma Unveils ‘Metabolic Frontier 2030’ With Targets for Five Launches

Peroxisomes Provide Backup Brown-Fat Heater in Mice, Nature Study Finds

Ultra-Processed Diet Drove Fat Gain in Men Even With Matched Calories, Trial Finds

ECHO Study Identifies Early BMI Patterns Linked to Childhood Obesity Risk